Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Han, Weiguo ^a,d   Wang, Tao ^a   Reilly, Andrew A ^b   Keller, Steven M ^d   Spivack, Simon D ^a,c,d  

^a WADSWORTH CENTER   (United States)

^b Biostatistics   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; MOUTHWASH; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR PAX5; TUMOR MARKER;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EXPIRED AIR; FEASIBILITY STUDY; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; PROMOTER REGION; SMOKING; BREATH ANALYSIS; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; GENETICS; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BREATH TESTS; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 77349104631     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-86     Document Type: Article

References (34)

1. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. Chest 2007, 132:29S-55S. 2, 10.1378/chest.07-1347, 17873159.
2. Johnson FL, Turic B, Kemp R, Palcic B, Sussman R, Voelker KG, Robinette E. Improved diagnostic sensitivity for lung cancer using an automated quantitative cytology system and uridine 5'-triphosphate-induced sputum specimens. Chest 2004, 125:157S-158S. 10.1378/chest.125.5_suppl.157S-a, 15136486.
3. Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, Hirsch FR, Byers T, Kennedy T, Miller YE, Keith RL, Franklin WA. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev 2004, 28:244-251. 10.1016/j.cdp.2004.04.007, 15350627.
4. Helmig S, Schneider J. Oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer. Expert Rev Mol Diagn 2007, 7:555-568. 10.1586/14737159.7.5.555, 17892364.
5. Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, Gray WH, Chen S, Li M, Roder H, Liebler DC, Bigbee WL, Siegfried JM, Weissfeld JL, Gonzalez AL, Ninan M, Johnson DH, Carbone DP, Caprioli RM, Massion PP. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2007, 2:893-901. 10.1097/JTO.0b013e31814b8be7, 17909350.
6. Maciel CM, Junqueira M, Paschoal ME, Kawamura MT, Duarte RL, Carvalho MG, Domont GB. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J Exp Ther Oncol 2005, 5:31-38.
7. Kikuchi T, Carbone DP. Proteomics analysis in lung cancer: challenges and opportunities. Respirology 2007, 12:22-28. 10.1111/j.1440-1843.2006.00957.x, 17207021.
8. Diederich S. CT screening for lung cancer. Cancer Imaging 2008, 8(Suppl A):S24-S26. 10.1102/1470-7330.2008.9005, 2582499, 18852077.
9. Aisner J. CT screening for lung cancer: are we ready for wide-scale application?. Clin Cancer Res 2007, 13:4951-4953. 10.1158/1078-0432.CCR-07-0315, 17785542.
10. Lichy MP, Aschoff P, Plathow C, Stemmer A, Horger W, Mueller-Horvat C, Steidle G, Horger M, Schafer J, Eschmann SM, Kiefer B, Claussen CD, Pfannenberg C, Schlemmer HP. Tumor detection by diffusion-weighted MRI and ADC-mapping--initial clinical experiences in comparison to PET-CT. Invest Radiol 2007, 42:605-613. 10.1097/RLI.0b013e31804ffd49, 17700275.
11. Blanchon T, Brechot JM, Grenier PA, Ferretti GR, Lemarie E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007, 58:50-58. 10.1016/j.lungcan.2007.05.009, 17624475.
12. Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines. Chest 2007, 132:69S-77S. 2, 10.1378/chest.07-1349, 17873161.
13. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 2005, 11:6505-6511. 10.1158/1078-0432.CCR-05-0625, 16166426.
14. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006, 66:3338-3344. 10.1158/0008-5472.CAN-05-3408, 16540689.
15. Hartung TK, Maulu A, Nash J, Fredlund VG. Suspected pulmonary tuberculosis in rural South Africa--sputum induction as a simple diagnostic tool?. S Afr Med J 2002, 92:455-458.
16. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006, 130:1541-1546. 10.1378/chest.130.5.1541, 17099035.
17. Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, Saetta M. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:6-14. 10.1164/rccm.200510-1659PP, 16556692.
18. Gessner C, Kuhn H, Toepfer K, Hammerschmidt S, Schauer J, Wirtz H. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 2004, 43:215-222. 10.1016/j.lungcan.2003.08.034, 14739043.
19. Carpagnano GE, Foschino-Barbaro MP, Mule G, Resta O, Tommasi S, Mangia A, Carpagnano F, Stea G, Susca A, Di Gioia G, De Lena M, Paradiso A. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 2005, 172:738-744. 10.1164/rccm.200503-439OC, 15947287.
20. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mule G, Pinto R, Tommasi S, Paradiso A. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008, 177:337-341. 10.1164/rccm.200707-1136OC, 17962633.
21. Han W, Cauchi S, Herman JG, Spivack SD. DNA methylation mapping by tag-modified bisulfite genomic sequencing. Anal Biochem 2006, 355:50-61. 10.1016/j.ab.2006.05.010, 16797472.
22. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432. 10.1038/nature05918, 17522676.
23. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447:433-440. 10.1038/nature05919, 17522677.
24. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054. 10.1056/NEJMra023075, 14627790.
25. Rakyan VK, Hildmann T, Novik KL, Lewin J, Tost J, Cox AV, Andrews TD, Howe KL, Otto T, Olek A, Fischer J, Gut IG, Berlin K, Beck S. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol 2004, 2:e405. 10.1371/journal.pbio.0020405, 529316, 15550986.
26. Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 2004, 20:3005-3012. 10.1093/bioinformatics/bth346, 15247106.
27. Cox DR, Snell EJ. Analysis of Binary Data. 1989, Chapman and Hall/CRC. Boca Raton, Second.
28. Paulson AS, Delehanty TA. Sensitivity Analysis in Experimental Design. In Computer Science and Statistics: Proceedings of the 14th Symposium on the Interface. 1982, 52-57. Springer-Verlag, New York, Heiner KW, Sacher RS, Wilkinson JW.
29. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002, 62:2370-2377.
30. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 2004, 64:3844-3848. 10.1158/0008-5472.CAN-03-2119, 15172992.
31. Schafer BW. Emerging roles for PAX transcription factors in cancer biology. Gen Physiol Biophys 1998, 17:211-224.
32. Bock C, Walter J, Paulsen M, Lengauer T. Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res 2008, 36:e55. 10.1093/nar/gkn122, 2425484, 18413340.
33. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007, 128:669-681. 10.1016/j.cell.2007.01.033, 17320505.
34. Bock C, Lengauer T. Computational epigenetics. Bioinformatics 2008, 24:1-10. 10.1093/bioinformatics/btm546, 18024971.